C4 Therapeutics is a cutting-edge brand that offers a new generation of medicine, revolutionizing the treatment of various diseases. Through their targeted protein degradation (TPD) approach, they aim to degrade specific disease-causing proteins, ultimately transforming lives. Their TORPEDO® Platform and focus on target selection allow them to harness the advantages of TPD effectively.

With an extensive pipeline of products, including CFT7455, CFT8634, CFT1946, and CFT8919, C4 Therapeutics is at the forefront of scientific innovation. Committed to excellence, C4 Therapeutics follows a rigorous Quality Policy Statement and provides valuable resources, publications, and an Expanded Access Program for healthcare providers. Their leadership team, board of directors, clinical advisory board, and scientific advisory board ensure their scientific advancements are backed by expert knowledge.

Driven by their values and fueled by a diverse team, C4 Therapeutics strives to make a significant impact on patients' lives. Join them on their mission to transform disease treatment and explore exciting career opportunities at C4 Therapeutics